| Anat Cohen-Dayag | |
| Nationality: |  Israel |
| Alma Mater: | Weizmann Institute of Science Ben-Gurion University |
| Thesis1 Title: | and |
| Thesis2 Title: | )--> |
| Thesis1 Url: | and |
| Thesis2 Url: | )--> |
| Thesis1 Year: | and |
| Thesis2 Year: | )--> |
| Doctoral Advisors: | )--> |
| Spouses: | )--> |
| Partners: | )--> |
Anat Cohen-Dayag is an Israeli businesswoman. She is president and chief executive officer of the Israeli biotechnology firm Compugen Ltd, a company involved in drug discovery. She previously worked as a scientist at the R&D department of Orgenics.
She holds a B.Sc. in Biology from the Ben-Gurion University, and has obtained an MSc in Chemical Immunology and a PhD in Biological Chemistry from the Weizmann Institute of Science.[1] [2] [3]